From: Physicochemical and nanomedicine applications of phyto-reduced erbium oxide (Er2O3) nanoparticles
S. No. | Groups | Dose mg kg−1 | Blood glucose level (GL) (mg dL−1) | ||||||
---|---|---|---|---|---|---|---|---|---|
Day 0 | Day 1 | Day 4 | Day 7 | Day 11 | Day 14 | Day 21 | |||
Group1 | After Alloxan + Tween 80 | 150 | 567.00 ± 3.46 | 507.00 ± 5.77 | 522.66 ± 3.75 | 500.66 ± 4.33 | 469.66 ± 2.60 | 454.33 ± 2.96 | 389.33 ± 4.50 |
Group2 | Normal control saline | 0.35 | 115.33 ± 7.86*** | 121.00 ± 3.51*** | 116.50 ± 2.66*** | 108.33 ± 2.89*** | 103.00 ± 4.50*** | 97.00 ± 1.50*** | 93.50 ± 1.60*** |
Group3 | Glibenclamide | 05 | 376.66 ± 1.20*** | 351.33 ± 5.20*** | 341.00 ± 3.66*** | 361.50 ± 2.50*** | 301.38 ± 2.33*** | 279.88 ± 3.80*** | 235.33 ± 2.33*** |
Group4 | HT-Er2O3 NPs | 30 | 503.66 ± 5.92*** | 458.66 ± 2.02*** | 375.00 ± 3.09*** | 310.66 ± 2.33*** | 298.00 ± 4.04*** | 205.33 ± 2.60*** | 185.66 ± 2.60*** |